NFKB1 and breast carcinoma: Considering that the PI3K subunit p85, NF-kB and Bcl2 are inhibited by plumbagin in human breast cancer cells [14], [15], this result suggests that its3 is a new molecular target of plumbagin and possibly contributes to the cytotoxic activity of this agent in human cancers.